Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/135256
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Prediction of clinically significant bleeding following wide-field endoscopic resection of large sessile and laterally spreading colorectal lesions: A clinical risk score
Author: Bahin, F.F.
Rasouli, K.N.
Byth, K.
Hourigan, L.F.
Singh, R.
Brown, G.J.
Zanati, S.A.
Moss, A.
Raftopoulos, S.
Williams, S.J.
Bourke, M.J.
Citation: American Journal of Gastroenterology, 2016; 111(8):1115-1122
Publisher: American College of Gastroenterology
Issue Date: 2016
ISSN: 0002-9270
1572-0241
Statement of
Responsibility: 
Farzan F. Bahin, MBBS, Hons, MPhil, FRACP, Khalid N. Rasouli, MBBS, Karen Byth, PhD, Luke F. Hourigan, MBBS, FRACP, Rajvinder Singh, MBBS, FRACP, Gregor J. Brown, MBBS, FRACP, PhD, Simon A. Zanati, MBBS, FRACP, Alan Moss, MBBS, FRACP, PhD, Spiro Raftopoulos, MBBS, FRACP, Stephen J. Williams, MBBS, FRACP, MD, and Michael J. Bourke, MBBS, FRACP
Abstract: OBJECTIVES: Clinically signifi cant bleeding (CSPEB) is the most frequent adverse event following wide-fi eld endoscopic mucosal resection (WF-EMR) of large sessile and laterally spreading colorectal lesions (LSL). There is limited knowledge regarding accurate prediction of CSPEB. We aimed to derive a score to predict the risk of CSPEB. METHODS: Data on patient and lesion characteristics and outcomes from WF-EMRs of LSL ≥20 mm at 8 referral hospitals were analyzed. The cohort was divided at random into equal sized training and test groups. Independent predictors of CSPEB in the training cohort were identified by multiple logistic regression analysis and used to develop a risk score. The performance of this score was assessed in the independent test cohort. RESULTS: Over 80 months to June 2015, 2,128 patients with 2,424 LSL were referred for WF-EMR. Two thousand and twelve patients were eligible for analysis. There were 135 cases of CSPEB (6.7%). In the training cohort of 1,006 patients, the independent predictors of CSPEB were lesion size >30 mm (odds ratio (OR) 2.5), proximal colonic location (OR 2.3), presence of a major comorbidity (OR 1.5), and epinephrine in injection solution (OR 0.57). The derived risk score comprised lesion size >30 mm (2 points), proximal colon (2 points), presence of major comorbidity (1 point), and absence of epinephrine use (1 point). The probabilities of CSPEB for scores of 0, 1, 2, 3, 4, and ≥5 in the training cohort were 1.5, 2.0, 5.6, 7.8, 9.1, and 17.5% and were 0.9, 6.7, 4.9, 6.2, 9.0, and 15.7% in the test cohort. The probabilities of CSPEB in those with low (score 0–1), medium (score 2–4), and elevated (score 5–6) risk levels were 1.7, 7.1, and 17.5% in the training cohort and 3.4, 6.2, and 15.7% in the test cohort. CONCLUSIONS: Patients at elevated risk of CSPEB can be identified using four readily available variables. This knowledge may improve the management of those undergoing WF-EMR and assist in designing studies evaluating CSPEB.
Keywords: Humans
Adenoma
Colorectal Neoplasms
Gastrointestinal Hemorrhage
Postoperative Hemorrhage
Colonoscopy
Embolization, Therapeutic
Hospitalization
Length of Stay
Reoperation
Logistic Models
Odds Ratio
Risk Assessment
Aged
Middle Aged
Australia
Female
Male
Endoscopic Mucosal Resection
Rights: © 2016 by the American College of Gastroenterology
DOI: 10.1038/ajg.2016.235
Published version: http://dx.doi.org/10.1038/ajg.2016.235
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.